Insiders Astria Therapeutics, Inc.

Equities

ATXS

US04635X1028

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-28 EDT			5-day change	1st Jan Change
9.1 ^USD	-1.30%		-3.50%	+18.49%

05-21	Oppenheimer Adjusts Astria Therapeutics Price Target to $25 From $29, Maintains Outperform Rating	MT
05-09	Astria Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Astria Therapeutics, Inc. Appoints Sunil Agarwal to the Board of Directors and Member of the Science and Technology Committee	04-09	CI
Astria Therapeutics, Inc. Appoints John Ruesch as Senior Vice President, Pharmaceutical Sciences and Technical Operations	23-07-17	CI
Astria Therapeutics, Inc. Promotes Andrea Matthews to Chief Business Officer	23-04-19	CI
Astria Therapeutics, Inc. Announces Resignation of Andrew Nichols as Chief Scientific Officer of the Company, Effective as of April 7, 2023	23-03-31	CI
Astria Therapeutics, Inc Appoints Chris Morabito as Chief Medical Officer	22-07-15	CI
Joanne Donovan to Resign as Chief Medical Officer of Catabasis Pharmaceuticals, Inc	21-04-16	CI
Catabasis Pharmaceuticals, Inc. Announces Executive Appointments	21-01-29	CI
Catabasis Pharmaceuticals, Inc. Appoints Noah Clauser as Chief Financial Officer	20-09-21	CI
Catabasis Pharmaceuticals, Inc. Names Ben Harshbarger as Senior Vice President, General Counsel	20-06-12	CI
Catabasis Pharmaceuticals, Inc. Announces Executive Changes	19-12-19	CI
Catabasis Pharmaceuticals Appoints Andrew A. Komjathy as Chief Commercial Officer	19-09-25	CI
Catabasis Pharmaceuticals, Inc. Announces Executive Changes	19-09-23	CI
Catabasis Pharmaceuticals, Inc. Appoints Hugh M. Cole as Director	19-07-31	CI
Catabasis Pharmaceuticals, Inc. Announces Resignation of Jean George as Member of Board of Directors and Member of Board Committees	19-06-05	CI
Catabasis Pharmaceuticals, Inc. Announces Directorate Changes	19-02-14	CI
Catabasis Pharmaceuticals Appoints Gregg Lapointe to its Board of Directors	19-01-04	CI
Catabasis Pharmaceuticals, Inc. Approves Election of Kenneth Bate as Class II Director from Class III Director	17-06-12	CI
Catabasis Pharmaceuticals, Inc. Announces Promotion of Ted Hibben to Chief Business Officer	17-02-17	CI
Catabasis Pharmaceuticals, Inc. Announces Departure of Rick Modi as Chief Business Officer, Effective February 10, 2017	17-01-31	CI
Catabasis Pharmaceuticals Announces Promotion of Andrew Nichols to Chief Scientific Officer and Angelika Fretzen to Senior Vice President of Product Development	16-10-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Astria Therapeutics, Inc.

Equities

ATXS

US04635X1028

Insiders

Filters